AAA May 2015

Weekly corporate venturing deal net: 25-29 May 2015

Intel Capital, the corporate venturing arm of semiconductor technology manufacturer Intel, has invested an undisclosed amount in Digital Specialty Chemicals (DSC), a Canada-based provider of advanced materials for the semiconductor, pharmaceutical and specialty chemical industries. DSC, which was founded in 1987, will use the money to upgrade its research and development capabilities and expand its… Continue reading Weekly corporate venturing deal net: 25-29 May 2015

Seres targets $100m from IPO

Seres Therapeutics, a US-based biotechnology company backed by nutritional health product manufacturer Nestlé Health Science, filed for an initial public offering on Nasdaq on Wednesday that could raise up to $100m. Seres is working on a cure for clostridium difficile, a form of bacterial bowl infection that affects patients with a weakened immune system. In… Continue reading Seres targets $100m from IPO